Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.298 USD | +6.43% | +1.02% | -93.33% |
Mar. 18 | LianBio(OTCPK:LIAN.Y) dropped from NASDAQ Composite Index | CI |
Mar. 15 | ADRs End Lower; Akso Health Group Declines 23% | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 178M |
---|---|---|---|---|---|
Net income 2021 | -196M | Net income 2022 | -110M | EV / Sales 2021 | - |
Net cash position 2021 | 378M | Net cash position 2022 | 298M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.08
x | P/E ratio 2022 |
-1.6
x | Employees | 163 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 40.81% |
1 day | +6.43% | ||
1 week | +1.02% | ||
Current month | -7.74% | ||
1 month | -4.09% | ||
3 months | -92.85% | ||
6 months | -91.39% | ||
Current year | -93.33% |
Managers | Title | Age | Since |
---|---|---|---|
Adam Stone
CEO | Chief Executive Officer | 44 | 19-09-30 |
Levvy Lv
PRN | Corporate Officer/Principal | 42 | 20-03-31 |
Nathan Chen
LAW | General Counsel | 56 | 20-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 51 | 20-07-31 | |
Adam Stone
CEO | Chief Executive Officer | 44 | 19-09-30 |
Wei Wei Chen
BRD | Director/Board Member | 58 | 22-04-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.12% | 4 M€ | -27.92% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.298 | +6.43% | 5,242 |
24-04-24 | 0.28 | -1.06% | 20,213 |
24-04-23 | 0.283 | +0.18% | 186,926 |
24-04-22 | 0.2825 | -2.59% | 6,172 |
24-04-19 | 0.29 | -1.69% | 5,547 |
Delayed Quote OTC Markets, April 25, 2024 at 03:47 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-93.33% | 30.29M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- LIANY Stock